Protecting the Selfless: Toward More Comprehensive Care for Pediatric Related Stem Cell Donors

In this issue of the journal Pulsipher et al. [1] describe findings from the multi-institutional National Heart, Lung, and Blood Institute –funded RDSafe study, a prospective North American trial evaluating hematopoietic stem cell (HSC) donors of all ages predonation through 1 year after the collection procedure. After an earlier report from the study showed that many pediatric donors experience decreased health-related quality of li fe after donation [2], a more detailed assessment of pain, toxicities, and serious adverse events was undertaken in 294 donors younger than age 18 years.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research